Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine
Clinical trial NCT02752906 · COMPLETED
Trial details
- NCT number
- NCT02752906
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-15
- Primary completion
- 2016-12-19
- Enrollment
- 810
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.